Finance committee  May I add to that? Monsieur Gagnon is talking on the biotech side. On the pharmaceutical side, where we are looking at the SR and ED tax credit, we're looking at the definition and whether the definition could be consistent with the OECD definition, which is to expand it to inc

Finance committee  The national pharmaceutical strategy was announced in September 2004. In principle it makes a lot of sense to work together to try to better the health care system. But in practice, we're seeing a lot of concern that some of these important products won't be recognized on an indi